| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.009 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |